PTC Therapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
18.09.23
/
50%
€22.80
Target price
18.09.24
€20.61
Performance (%)
37.72%
Price
23.08.24
€30.00
Summary
This prediction is currently active. The price for PTC Therapeutics Inc. has massively increased, which is bad news for the SELL prediction by The_Goldman_Sachs_Gr. This prediction currently runs until 18.09.24. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | 0.685% | 0.685% |
iShares Core DAX® | 1.665% | 1.692% |
iShares Nasdaq 100 | -0.475% | 1.483% |
iShares Nikkei 225® | 2.620% | 4.475% |
iShares S&P 500 | -0.091% | 1.099% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $35.00 to $22.00. They now have a "sell" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.60
28.05.24
28.05.24
€29.42
28.05.25
28.05.25
-6.55%
23.08.24
23.08.24
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€35.00
21.05.24
21.05.24
€29.48
21.05.25
21.05.25
-14.29%
23.08.24
23.08.24